Company Search:
Advanced Search
Sponsored Links
Hypera SA Company Snapshot
Hypera SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hypera SA with three other pharmaceutical manufacturers in Latin America: Diagnosticos Da America SA (2017 sales of 3.40 billion Brazilian Reals [US$924.71 million] of which 100% was servi os auxiliares), Fleury SA (2.38 billion Brazilian Reals [US$648.25 million] of which 84% was Diagnostic Medicine), and Genomma Lab Internacional Sab De Cv which is based in Mexico (12.08 billion Mexican Pesos [US$617.09 million] ).

Sales Analysis. Hypera SA reported sales of 3.64 billion Brazilian Reals (US$989.77 million) for the year ending December of 2017. This represents an increase of 10.6% versus 2016, when the company's sales were 3.29 billion Brazilian Reals. The sales level in 2017 was fairly close to the level five years ago: in 2012, Hypera SA had sales of 3.87 billion Brazilian Reals.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hypera SA
  Stock Performance Chart for Hypera SA
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 27.50
(Figures in Brazilian Reals)
1 Week -7.5%   13 Weeks -18.2%  
4 Weeks -25.3%   52 Weeks -6.8%  
Hypera SA Key Data:
  Ticker: HYPE3 Country: Brazil
  Exchanges: SOP Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 3,638,458,000
(Year Ending Jan 2018).
Employees: 6,513
  Currency: Brazilian Reals Market Cap: 17,381,282,105
  Fiscal Yr Ends: December Shares Outstanding: 632,046,622
  Share Type: Ordinary Closely Held Shares: 264,871,655
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.